ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1394

Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study

Patompong Ungprasert1, Cynthia S. Crowson2 and Eric L. Matteson3, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Arthritis, epidemiologic methods and sarcoidosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster Session II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  The epidemiology and clinical characteristics of sarcoid arthropathy are not well-described as only referral-based studies have been reported. This study aimed to use the data from a geographically well-defined population to characterize the clinical characteristics of sarcoid arthropathy.

Methods: An inception cohort of patients with incident sarcoidosis in 1976-2013 in a geographically well-defined population was identified based on comprehensive individual medical record review. Inclusion required physician diagnosis supported by histopathology and radiologic features of intrathoracic sarcoidosis, compatible clinical presentation, and exclusion of other granulomatous diseases.  Tissue samples were considered positive if they demonstrate non-caseating granuloma without evidence of acid-fast bacilli or fungi. The only exception to the requirement of histopathological confirmation was stage I pulmonary sarcoidosis that required only radiographic evidence of symmetric bilateral hilar adenopathy. Patients with joint pain were then identified from this cohort. Data were collected on pattern of joint involvement, associated cutaneous and systemic symptoms, physical examinations and inflammatory markers.

Results: In 1976-2013, 345 incident cases of sarcoidosis were identified (mean age 45.6 years and 50.4% female). Symptoms of joint pain occurred in 42 patients (mean age 41.2 years and 57.1% female), and 35 patients had swollen joint(s) on physical examination. Most patients had arthralgia prior to the diagnosis of sarcoidosis with an average time to diagnosis of 21 days. Approximately half of patients had fever and elevated sedimentation rate at diagnosis (48% and 46%, respectively).

Of the 35 cases with objective evidence of synovitis, oligoarthritis (two to four joints) was the most common pattern (88%) followed by monoarthritis (6%) and polyarthritis (6%). Ankles were involved in 91% of cases (14% one ankle and 77% both ankles). In the majority of patients (88%), the arthritis resolved within 6 weeks.    

The most common associated cutaneous manifestation was erythema nodosum followed by subcutaneous nodule/plaque (31% and 5%, respectively). The classic Lofgren syndrome (arthritis, erythema nodosum and hilar adenopathy) was observed in 11 patients (26%).

Conclusion: Inflammatory arthritis occurred in a minority of patients with sarcoidosis. Acute oligoarthritis with bilateral ankles involvement was the most common pattern of sarcoid arthropathy. A significant portion of patients also had systemic symptoms as well as erythema nodosum.


Disclosure: P. Ungprasert, None; C. S. Crowson, None; E. L. Matteson, Novartis/Sanofi/Centocor-Jansen/Celgene/Amgen/Roche/Genentech/Mesoblast/Pfizer, 2.

To cite this abstract in AMA style:

Ungprasert P, Crowson CS, Matteson EL. Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/clinical-characteristics-of-sarcoid-arthropathy-a-population-based-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-of-sarcoid-arthropathy-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology